Abstract
ObjectiveTo investigate the relationship between cardiac diastolic dysfunction and outcomes in patients with pulmonary arterial hypertension (PAH) and to clarify the potential effect of two-dimensional echocardiography (2D-echo) on prognostic value in patients with PAH.MethodsPatients diagnosed with PAH (as WSPH (World Symposia on Pulmonary Hypertension) classification I) confirmed by right heart catheterization (RHC), received targeted monotherapy or combination therapy. 2D-echo parameters, World Health Organization (WHO) functional classification and 6-minute walking distance (6MWD) were recorded. The clinical prognosis of patients was assessed by the correlation between echo parameters and clinical 6MWD using receiver operating characteristic (ROC) curve analysis.ResultsFifty-eight patients were included. Left and right ventricular diastolic dysfunction (LVDD and RVDD) scores measured by 2D-echo had good correlation with 6MWD at baseline (rLVDD = −0.699; rRVDD = −0.818, both P<0.001) and at last follow-up (rLVDD = −0.701; rRVDD = −0.666, both P<0.001). Furthermore, bi-ventricular (LVDD+RVDD) scores measured by 2D-echo had a better correlation with 6MWD at baseline and last follow-up (r = −0.831; r = −0.771, both P<0.001). ROC curve analysis showed that the area under curves (AUCs) for LVDD score, RVDD score and (LVDD+RVDD) scores were 0.823 (P<0.0001), 0.737 (P = 0.0002), and 0.825 (P<0.0001), respectively. Compared with ROC analysis of other single parameters, cardiac diastolic function score was more accurate in predicting survival in patients with PAH.ConclusionLVDD score, RVDD score and (LVDD+RVDD) scores yielded a comprehensive quantitative assessment of LV and RV diastolic function that correlated moderately with clinical functional parameters and might be useful in the assessment of PAH.
Highlights
Echocardiography is used mainly for preliminary screening in patients with suspected pulmonary arterial hypertension (PAH)
Compared with cardiac magnetic resonance imaging (MRI), which is the gold standard for cardiac functional detection [9, 10], few echo parameters predicting the prognosis of PAH have been identified
Hemodynamic parameters measured by right heart catheterization (RHC) were: systolic pulmonary artery pressure (SPAP) 73.0¡23.6 mm Hg, DPAP 39.0¡13.0 mm Hg, mean pulmonary arterial pressure (MPAP) 51.7¡15.4 mm Hg, pulmonary vascular resistance (PVR) 11.6¡5.3 Wood units, and CO 4.0¡1.3 L/min
Summary
Echocardiography (echo) is used mainly for preliminary screening in patients with suspected pulmonary arterial hypertension (PAH). Compared with cardiac magnetic resonance imaging (MRI), which is the gold standard for cardiac functional detection [9, 10], few echo parameters predicting the prognosis of PAH have been identified. As a result of its non-invasive nature, low cost, and lack of radiation, echo is a widely available imaging technique that is suitable for tentative clinical diagnosis and follow-up studies of PAH. It is of clinical importance to investigate echo parameters in evaluating heart function and predicting the prognosis of patients with PAH.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have